Mariner, LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Mariner, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$27.21 - $39.48 $604,034 - $876,416	22,199 New	22,199 $634,000
Q4 2022 Feb 14, 2023	BUY	$28.0 - $40.56 $22,204 - $32,164	793 Added 11.41%	7,740 $314,000
Q3 2022 Nov 10, 2022	BUY	$29.63 - $48.31 $205,839 - $335,609	6,947 New	6,947 $230,000
Q3 2019 Nov 13, 2019	SELL	$26.26 - $34.86 $261,838 - $347,589	-9,971 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$17.43 - $28.82 $173,794 - $287,364	9,971 New	9,971 $264,000

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $1.96B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

Stay updated on Mariner, LLC with notifications on news.